• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchElicio Therapeutics
    Picture of Elicio Therapeutics logo

    ELTX — Elicio Therapeutics News Story

    $1.900.000.00%
    us flag iconLast trade - 00:00
    HealthcareMicro CapSucker Stock
    • Market Cap
      $51.47m
    • Enterprise Value
      $37.53m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • ELTX Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    ELTX Dividends
    All News

    NASDAQ RESUMED AT 04:35 PM

    Picture of Elicio Therapeutics logoElicio Therapeutics
    29/06/2022 21:35
    NASDAQ RESUMED  ANGN.O  AT 04:35 PM
    

    Recent news on Elicio Therapeutics

    See all news
    • Factbox: Moderna-Merck melanoma vaccine leads race for first therapeutic cancer vaccine

      19/08/2026 15:46
    • Elicio Therapeutics Q2 net loss narrows as R&D expenses fall

      13/08/2026 21:09
    • Elicio Therapeutics Inc expected to post a loss of 54 cents a share - Earnings Preview

      03/08/2026 12:16
    • U.S. STOCKS ON THE MOVE-Datadog, Terawulf, Paychex

      15/06/2026 19:13
    • Elicio shares slide after pancreatic cancer vaccine falls short in mid-stage study (updated)

      15/06/2026 18:03

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.